Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,623
datasets available to search
ShareScore release 0.9.0
Dataset results
1,623 results for “hemodialysis”
Inspiratory Muscle Training for Chronic Kidney Disease Patients on Hemodialysis
ClinicalTrials.gov study NCT05241652. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients
ClinicalTrials.gov study NCT02817555. IPD Sharing: NO. Countries: 0. Publications: 2.
Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA
ClinicalTrials.gov study NCT01670474. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients
ClinicalTrials.gov study NCT00205556. IPD Sharing: Not stated. Countries: 3. Publications: 21.
The Effect of Home-Based Walking on Symptoms and Health Profile of Hemodialysis Patients
ClinicalTrials.gov study NCT07272070. IPD Sharing: NO. Countries: 1. Publications: 5.
Effect of Bee Venom on Chronic Kidney Disease-Mineral Bone Disorders in Hemodialysis Patients: a Randomized Controlled Trial
ClinicalTrials.gov study NCT06901102. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients
ClinicalTrials.gov study NCT04054128. IPD Sharing: NO. Countries: 1. Publications: 15.
Data from: Clinical Outcomes Associated with the use of the NexSite™ Hemodialysis Catheter with New Exit Barrier Technology: Results from a Prospective, Observational Multi-center Registry Study
Open the record for dataset details and reuse information.
Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic
<p><strong>Introduction:</strong> Pneumonia of unknown cause was detected on 30 December 2019 in China. It was categorized as an outbreak and named as COVID-19 by the World Health Organization. The pandemic affects all people, but patient groups such as hemodialysis (HD) patients have been particularly affected. We do not know if refugees suffered more during the outbreak. In this study, we compared depressive symptom frequency between Syrian refugee HD patients and Turkish ones.</p> <p><strong>Methods:</strong> The study had a single-center, cross-sectional design. Demographic and clinical data were collected retrospectively from patients' files containing details about past medical history, demographic variables and laboratory values. Validated Turkish and Arabic forms of Beck Depression Inventory (BDI) were used to assess depressive symptoms. BDI scores were compared according to nationality, demographic features and clinical data. A BDI score more than 14 was accepted as suspicion of depression.</p> <p><strong>Results:</strong> 119 patients were enrolled in the study. After the exclusion of 22 patients, 75 Turkish and 22 Syrian patients were included for further analysis. The median BDI (interquartile range) score for Turkish and Syrian patients were 12 (7-23) and 19.5 (12.7-25.2), respectively (p=0.03). Suspicion of depression was present at 42.7% of Turkish, and 72.7% of Syrian HD patients (p=0.013). Regarding all patients, phosphorus level, Kt/V, and nationality were significantly different between patients with and without suspicion of depression (p=0.023, 0.039, 0.013, respectively).</p> <p><strong>Conclusion:</strong> Syrian patients had higher BDI scores and more depressive symptoms than Turkish patients. Additional national measures for better integration and more mental support to Syrian HD patients are needed. </p>
Gut dysbiosis and mortality in hemodialysis patients
<p>Gut dysbiosis, characterized by decreased microbial diversity, promotes inflammation. Persistent inflammation plays a pathogenic role in complications of chronic kidney disease (CKD). However, little is known about the relationship between gut dysbiosis and adverse outcomes in patients with CKD. First, we examined the association of microbial diversity with all-cause mortality in CKD patients receiving hemodialysis (n=109). The microbial composition of fecal samples was profiled by means of 16S ribosomal RNA gene sequencing. Microbial diversity was calculated using the Simpson index. Participants were stratified into higher- (above the median) and lower-diversity (below the median) groups and were followed up for a median of 2.1 years. Kaplan-Meier analyses revealed a significant association between higher diversity and a lower risk of death (log-rank P=0.015). After adjustment for patient characteristics and comorbid conditions, the risk of death among patients with higher diversity was 74% lower than that among patients with lower diversity (hazard ratio, 0.26; 95% CI, 0.07 to 0.95). Next, in a matched case-control study, we compared the microbial composition between nonsurvivors and survivors who were matched 1:4 for age and sex. We observed significantly lower values of microbial diversity and higher levels of proinflammatory cytokines among nonsurvivors (n=14) than survivors (n=56). Specifically, the relative abundance of Succinivibrio and Anaerostipes, two short-chain fatty acid-producing bacteria, was markedly reduced in nonsurvivors compared with survivors. In conclusion, a unique gut microbial composition is associated with an increased risk of mortality among hemodialysis patients and may be used to identify subjects with a poor prognosis.</p>
Data from: Urgent-start peritoneal dialysis and hemodialysis in ESRD patients: complications and outcomes
Background: Several studies have suggested that urgent-start peritoneal dialysis (PD) is a feasible alternative to hemodialysis (HD) in patients with end-stage renal disease (ESRD), but the impact of the dialysis modality on outcome, especially on short-term complications, in urgent-start dialysis has not been directly evaluated. The aim of the current study was to compare the complications and outcomes of PD and HD in urgent-start dialysis ESRD patients. Methods: In this retrospective study, ESRD patients who initiated dialysis urgently without a pre-established functional vascular access or PD catheter at a single center from January 2013 to December 2014 were included. Patients were grouped according to their dialysis modality (PD and HD). Each patient was followed for at least 30 days after catheter insertion (until January 2016). Dialysis-related complications and patient survival were compared between the two groups. Results: Our study enrolled 178 patients (56.2% male), of whom 96 and 82 patients were in the PD and HD groups, respectively. Compared with HD patients, PD patients had more cardiovascular disease, less heart failure, higher levels of serum potassium, hemoglobin, serum albumin, serum pre-albumin, and lower levels of brain natriuretic peptide. There were no significant differences in gender, age, use of steroids, early referral to a nephrologist, prevalence of primary renal diseases, prevalence of co-morbidities, and other laboratory characteristics between the groups. The incidence of dialysis-related complications during the first 30 days was significantly higher in HD than PD patients. HD patients had a significantly higher probability of bacteremia compared to PD patients. HD was an independent predictor of short-term (30-day) dialysis-related complications. There was no significant difference between PD and HD patients with respect to patient survival rate. Conclusion: In an experienced center, PD is a safe and feasible dialysis alternative to HD for ESRD patients with an urgent need for dialysis.
Prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa
<p><span><span><b>Background</b> </span></span></p> <p><span><span>Due to its invasive procedure patients on hemodialysis (HD) are at high risk of infections. Infections acquired in dialysis units can prolong hospitalization date and/or prolong illness in patients, and increase treatment cost. There are no adequate data on the prevalence of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections in HD patients. Therefore, this study aimed to estimate the pooled prevalence and associated factors of HBV and HCV infections among HD patients in Africa.</span></span></p> <p><span><span><b>Method</b></span></span></p> <p><span><span>The databases PubMed, Medline, EMBASE, Cochrane library, web of science, African Journals Online, Science Direct, and Google Scholar were searched to identify relevant studies. The review was performed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data were extracted independently by two authors and analyzed using STATA 11. A random-effect model was fitted to estimate the pooled prevalence with their 95% confidence interval. To detect publication bias funnel plots analysis and Egger weighted regression tests were done.</span></span></p> <p><span><span><b>Results</b></span></span></p> <p><span><span>The overall pooled prevalence of HBV and HCV infection among HD patients in Africa was 9.88% (95% CI: 7.20-12.56) I<sup>2</sup>=97.9% and 23.04% (95% CI: 18.51-2757) I<sup>2</sup>=99.6%, respectively. In addition, the pooled prevalence of HBV and HCV co-infection was 7.18% (95% CI: 3.15-11.20) I<sup>2</sup>=99.6%. Duration of dialysis was found to be the contributing factor for the occurrence of HBV and HCV among HD patients (OR=1.44; 95% CI: 1.04, 2.01).</span></span></p> <p class="Default"><b>Conclusion</b></p> <p class="Default">This study showed that there is high prevalence of HBV and HCV infections in HD patients in Africa. Therefore, strict adherence to precautions of infection control measures, isolation of seropositive patients, improvement in infrastructures, adequate screening of HBV and HCV for the donated blood, and decentralized HD services is needed to minimize the risk of HBV and HCV infections in HD facilities.</p>
Assessment of Adherence to Medications and Prevalence of depression among hemodialysis patients
<p>this file cotain supplementary information about article </p>
Hot and Cold Compress in Hemodialysis
ClinicalTrials.gov study NCT04681521. IPD Sharing: NO. Countries: 1. Publications: 0.
Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique
ClinicalTrials.gov study NCT02814721. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-term Hemodialysis Catheter Removal and Delayed Replacement, Versus Exchange Over a Guidewire to Treat Catheter Related Blood Stream Infection
ClinicalTrials.gov study NCT03054714. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients
ClinicalTrials.gov study NCT02570854. IPD Sharing: UNDECIDED. Countries: 4. Publications: 0.
Pulmonary Function Tests in Children and Adolescents With End Stage Renal Disease On Regular Hemodialysis
ClinicalTrials.gov study NCT06106438. IPD Sharing: Not stated. Countries: 0. Publications: 3.
An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis
ClinicalTrials.gov study NCT02033317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
ClinicalTrials.gov study NCT02331680. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.